How GLP‑1 medicine are reshaping magnificence and wellness innovation

Over the previous few years, the rise of GLP‑1 receptor agonist medicine akin to Ozempic and Wegovy has dramatically affected the well being and wellness trade —and can seemingly proceed to take action.

The medicine works to sluggish digestion and curb cravings, which ends up in vital weight reduction in a brief time period for a lot of customers.

Because of this, these customers might search out new well being and wonder merchandise to suit their newly slim look, however there are additionally new wants being created, as using these drugs can have an effect on their facial construction and pores and skin high quality.

To seek out out extra about how this motion is impacting magnificence innovation, we spoke to Magnificence Strategist at WGSN, Pia Fisher.

Hello Pia, how are GLP‑receptor medicine impacting customers’ magnificence and wellness wants?

Ozempic and different GLP‑1 drugs aren’t simply trending, they’re reworking. What started as a metabolic breakthrough is now a cultural and business disruptor, reshaping perceptions of weight, wellness and id.

As weight‑loss injectables transfer mainstream, we’re seeing customers reframe magnificence as emotional infrastructure: a coping mechanism, a confidence amplifier and a technique to stabilize their sense of self throughout fast transformation.

Each class has a possibility to pivot, increase or adapt to fulfill the evolving wants of GLP‑1 customers. From physique care that helps quick‑altering pores and skin and publish‑weight‑loss pores and skin laxity to ingestibles that nutritionally help power, pores and skin and wonder from inside, GLP‑1s are forcing a rethink. As unintended effects like hair thinning or scent sensitivity emerge, customers will search magnificence options that soothe, consolation and rebuild. Cosmetics will probably be a supply of renewed pleasure and visibility, empowering customers to reconnect with their evolving sense of id.

Now could be the time for magnificence manufacturers to behave and develop product options that replicate organic wants and emotional shifts, seizing the rising alternatives of the GLP‑1 age.

What sorts of innovation are we seeing round this matter?

In sensible phrases, GLP‑1 utilization is translating into extremely particular product calls for. Speedy weight reduction can result in pores and skin laxity, facial quantity shifts, dullness and hair thinning, so manufacturers are prioritizing firming applied sciences, collagen‑supporting actives, barrier restore and substances that improve mobile power.

Haircare innovation is accelerating round hair loss, scalp well being and density‑boosting therapies. In perfume, behaviors are polarizing: Some customers keep away from wealthy gourmands when experiencing nausea or heightened scent sensitivity, whereas others lean into tremendous‑candy, dessert‑like fragrances as a meals‑adjoining deal with second.

Past topical care, innovation is increasing into what we describe as “weight‑loss wellness companions”: dietary supplements, electrolyte blends, vitamin patches and acupressure instruments designed to mitigate unintended effects and help the physique extra holistically.

We’re additionally seeing manufacturers straight name out GLP‑1‑associated issues in product copy and campaigns, whereas actively recruiting GLP‑1 customers into medical trials to substantiate claims towards the particular pores and skin, hair and physique adjustments related to the medicine.

How do you suppose this can evolve within the upcoming years?

Adoption is already vital within the US, the place roughly one in eight adults are reported to be utilizing GLP‑1 drugs, and development is predicted to speed up throughout Europe and elements of Asia. As oral variations of the medicine and microdosing fashions enter the market, the GLP‑1 motion will grow to be additional normalized inside on a regular basis routines.

This can solidify GLP‑1s not as a brief‑time period spike however as a structural shift, additional validating the emergence of a devoted GLP‑1 magnificence and wellness class.

On the identical time, we anticipate intensifying pattern tensions. Alongside widespread pharmaceutical adoption, a counterculture will develop, interesting to pharma‑hesitant customers. This can drive demand for pure weight‑help dietary supplements, lymphatic instruments and slower, programs‑primarily based well-being options. This can be a pattern we’ve dubbed “Fake‑zempic” and is certainly one of WGSN’s prime developments for 2026.

What are your key strategic takeaways for manufacturers which will wish to innovate on this house?

• Reposition magnificence as emotional infrastructure. For customers present process fast physique change, magnificence turns into a coping mechanism, confidence amplifier and id stabilizer, bridging the hole between bodily transformation and sense of self.
• Audit your portfolio via a GLP‑1 lens. Speedy weight reduction creates new wants and issues: pores and skin laxity, facial quantity shifts, dullness and fatigue. Prioritize firming applied sciences, collagen‑supporting actives, barrier restore and substances that improve mobile power.
• Construct “weight‑loss wellness companions.” Increase past aesthetics into dietary supplements, ingestibles and instruments that assist mitigate unintended effects and help the physique holistically.
• Future‑proof for the Fauxzempic countertrend. Alongside GLP‑1 adoption, a resistance motion is rising—from “Fauxzempic” magnificence hacks to slower, longevity‑led options. Future‑proof by balancing fast‑repair aesthetics with sustained, programs‑primarily based well-being.

Pia Fisher, Magnificence Strategist at WGSN will current the session: “Magnificence within the Age of GLP-1—The New Magnificence Alternative” at in-cosmetics International on Tuesday, April 14, 3 to three:45 p.m. within the Advertising and marketing Developments Theater on the Paris Expo Porte de Versailles, France.